AI startup ByteBrain is transforming clinical trials with agent-based optimization, cutting costs, boosting efficiency, and ...

Industry experts gathered at the Outsourcing in Clinical Trials East Coast 2025 conference to discuss artificial intelligence ...

The landscape of clinical trials is rapidly transforming. As we move through 2025, smarter technologies and patient-centric ...

The Food and Drug Administration has gone all in on AI since Martin Makary, M.D., took over the agency, most recently ...

Neuroscience technology company Brooklyn Health is using artificial intelligence to target a fundamental problem in neurology ...

To create truly adaptable strategies, you have to hammer out the core problems and explore multiple solutions.

AI will greatly lessen the effort of the discovery process, bringing more novel therapies to the forefront faster than ever ...

Wandercraft, a maker of self-balancing robotic mobility systems, has secured $75 million in funding to accelerate AI-powered ...

AI may provide an answer to the question of whether drugs initially developed and prescribed for non-neurodegenerative physical conditions can be used to treat individuals with Parkinson’s disease.

Regarding AI in the dermatology community, ‘there’s fear, but there’s also enthusiasm — sometimes enthusiasm to the point of ...

During a panel discussion on AI in clinical research, Prasanna Rao, Chief Products and Innovation officer at Saama emphasised the importance of making protocol data available to large language ...